Atlas Trials

A Study to Investigate Improvement in Pruritus of Lichen Simplex Chronicus With Dupilumab Injections Compared With Placebo in Male and Female Participants Aged at Least 18 Years (STYLE 2)

Clinical trial NCT06687980 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06687980
Sponsor
Sanofi
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Lichen Simplex Chronicus
Start date
2024-11-25
Primary completion
2026-06-08
Enrollment
138

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.